pharmaphorum

JANUARY 13, 2021

IO Biotech, an oncology specialist formed and backed by Denmark’s Novo Holdings, has raised €127 million ($155 million) to further develop its cancer vaccine technology that has boosted efficacy of PD-1 immunotherapy in early trials. The post IO Biotech raises $155m to develop breakthrough cancer vaccine appeared first on.

Vaccines 95

Vaccines Immunity Immunization Compounding 95

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108

Vaccines Drug Pricing Biosimilars Documentation 108

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccines 96

Vaccines Pharmaceutical Manufacturing Labelling Compounding 96

pharmaphorum

NOVEMBER 25, 2020

AstraZeneca’s research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by accident. According to Reuters , the AstraZeneca development team made a minor mistake that made them realise they could significantly boost the success rate of the vaccine, codenamed AZD1222.

Vaccines 119

Vaccines Compounding 119

STAT

NOVEMBER 18, 2022

The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world. The agency issued 62 warning letters and 23 import alerts related to drugs, excluding compound-related actions.

Diabetes 244

Diabetes Biosimilars Documentation Compounding 244

pharmaphorum

MARCH 26, 2021

The European Union has stopped short of export controls on vaccines after leaders met at a summit to discuss the issue of shortfalls in supply. At the meeting of the European Council leaders said that toughening export controls was an option but a post-summit statement emphasised the importance of global supply chains to produce vaccines.

Vaccines 59

Vaccines Compounding 59

Pharmaceutical Technology

FEBRUARY 14, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on I nnovation in Pharmaceuticals: Isotropically modified heterocyclic compounds. However, not all innovations are equal and nor do they follow a constant upward trend.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Business Review

JANUARY 17, 2025

grant from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of needle-free vaccines against Disease X, earlier in the month. Also, it announced plans for the first Phase II trial of its needle-free measles/rubella vaccine which was supported by a $7.5m The company received a $3.7m

Vaccines 52

Vaccines Compounding 52

Community Pharmacy

SEPTEMBER 28, 2023

Luckily, two new RSV vaccines have been developed and approved to help combat this risk and will be available this fall. If you are concerned about your vulnerability to RSV and are over the age of 60, then you can book a time slot immediately to receive the vaccine at your nearest Community Pharmacy location. What is RSV?

Vaccines 59

Vaccines Community Pharmacies Immunity Immunization 59

pharmaphorum

OCTOBER 27, 2020

Pfizer is one of the front-runners in the race to approve a COVID-19 vaccine but the US company has had to weather lower revenues for the third quarter due to the ongoing impacts of COVID-19. No reason was given for the cut, but the drug is still in active combination trials, suggesting that will be the future of the compound.

Biosimilars 104

Biosimilars Vaccines Hospitals Compounding 104

Digital Pharmacist

JULY 11, 2023

Immunizations & Vaccinations Independent pharmacies are ideally positioned to provide convenient immunization services to their communities. By offering a range of vaccinations, such as influenza, pneumonia, shingles, and travel vaccines, pharmacies can attract new customers while supporting public health initiatives.

Independent Pharmacies 98

Independent Pharmacies Medication Therapy Management (MTM) Compounding Scheduling Appointments 98

pharmaphorum

OCTOBER 21, 2022

The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this. The emergence of COVID-19 meant that public awareness around vaccination and its importance in fighting the spread of infectious disease has increased rapidly.

Vaccines 98

Vaccines Immunity Immunization Compounding 98

epicur

MARCH 10, 2025

My first job here with Stokes was as a sales rep selling human compounded medication. There’s still a lack of understanding of the difference between a 503A traditional compounding pharmacy versus a 503B outsourcing facility. Going into compounding was challenging because compounding is different than traditional retail.

Compounding 52

Compounding Compounding Pharmacies Customer Service Hospitals 52

European Pharmaceutical Review

MARCH 11, 2024

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al.

Sterile Compounds 98

Sterile Compounds Compounding Packaging Pharmaceutical Companies 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. According to the report, European production has grown by approximately 5.4 percent annually in recent years.

Packaging 105

Packaging Vaccines Compounding 105

European Pharmaceutical Review

OCTOBER 27, 2022

For instance, small and mid-sized biotech companies invested heavily in developing vaccines. To date, 747 novel compounds are in production. Sectors such as research, testing, medical labs and pharmaceutical manufacturing expanded greatly during the pandemic, due to high demand for COVID-19 therapeutics. Sluggish economic growth.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Vaccines Compounding 105

pharmaphorum

AUGUST 27, 2020

In the UK, structural problems of the AIM market have compounded these problems by driving institutional investors away from relatively illiquid shares. Moreover, the range of companies benefiting from investor interest has not been limited to those developing a vaccine. COVID-19 sparks change.

Vaccines 122

Vaccines Drug Pricing Compounding Immunity 122

European Pharmaceutical Review

MAY 7, 2024

percent compound annual growth rate (CAGR) between 2024 to 2029. Injectable vaccines activate the immune system to help to prevent infectious conditions such as influenza. A new report by MarketsandMarkets has predicted that the injectable drug delivery market will reach an 8.6 The market is anticipated to value $1139.4

Vaccines 94

Vaccines Compounding Immunity Immunization 94

European Pharmaceutical Review

NOVEMBER 6, 2023

million in 2023, with a predicted compound annual growth rate (CAGR) of 4.1 Demand for cell lines “in drug development , vaccine production, and therapeutic research is surging”, setting the market up for significant expansion, Ghosh noted. Total cell line product sales are expected to reach $3,124.4 percent through the next decade.

Biosimilars 105

Biosimilars Compounding Vaccines Drug Development 105

European Pharmaceutical Review

APRIL 11, 2023

Therefore, the projected compound annual growth rate (CAGR) is 5.7 The key drivers of this industry include advancements in bioprocessing, development of novel microbial strains for production of high-value compounds and the rising demand for biopharmaceutical products such as antibiotics, vaccines and enzymes. percent by 2033.

Compounding 98

Compounding Biosimilars Vaccines 98

Pharma Pathway

SEPTEMBER 15, 2022

JD: Set -up and executive reactions for synthesize of target molecules/ Compounds. Note : For Walk-In Interviews along with your CV, Please Carry three months pay slips, last increment letter & Vaccination certificate. Qualification: M.Sc (Medicinal/ Organic Chemistry). Experience: 02 to 10 years. Date: 17th Sept’ 2022.

Compounding 82

Compounding Vaccines 82

Express Pharma

JULY 12, 2024

Now, Michael Mitchell and a team at the University of Pennsylvania have addressed this challenge with a novel approach that leverages a compound library fabrication technique known as “click-like chemistry” to create LNPs in a single, simple step.

Immunity 103

Immunity Immunization Compounding Vaccines 103

Eye on FDA

JANUARY 6, 2021

That may be less a reflection on the impact of COVID than it is the fact that so many investigational compounds come through the system with an enhanced status that may diminish the need for advisory committee input. While not full licensure, the mechanisms for approval did utilize agency resources. Happy New Year, by the way. Share this:

Compounding 82

Compounding Vaccines 82

European Pharmaceutical Review

MARCH 27, 2023

A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 percent between 2022 and 2027. According to the data, the market is forecasted to increase by $2,487.91 The research includes historic market data from 2017 to 2021, using 2022 as the base year.

Compounding 115

Compounding Vaccines 115

pharmaphorum

AUGUST 19, 2022

US startup Dr B – formed in 2021 to help match patients seeking a COVID-19 vaccine to suppliers with leftover stock – is branching out into antivirals with the help of an $8 million fundraising. The post Dr B raises $8m for telehealth service to deliver COVID antivirals appeared first on.

Vaccines 98

Vaccines Compounding 98

European Pharmaceutical Review

NOVEMBER 28, 2023

Having been valued at $112 billion in 2022, the worldwide cold storage market is projected to witness a 12 percent compound annual growth rate (CAGR) between 2023 and 2032, according to a report by Towards Healthcare. Therefore, by the end of 2032, the market will value an estimated $383.05 billion, the research projected.

Compounding 98

Compounding Vaccines 98

Eye on FDA

AUGUST 4, 2021

The reason they are included here is that they could be a factor in the need for fewer advisory committee meetings – if these candidate compounds are demonstrating promise that gets them more intensive oversight it may negate the need for outside counsel.

Clinical Pharmacology 122

Clinical Pharmacology Compounding Vaccines 122

pharmaphorum

NOVEMBER 16, 2022

Cases of drug-resistant TB (DR-TB) rose 3% in 2021 over the previous year, the first increase since record-keeping started in 2004, according to the WHO report, which called for countries to move quickly to restore access to essential services to treat the disease, as well as greater investment in new vaccines and therapeutics.

Compounding 98

Compounding Vaccines 98

pharmaphorum

AUGUST 25, 2022

Novartis started a review of the business in October 2021, after Sandoz had been suffering from pressure on sales and operating profits for several years due mainly to pricing pressures, which were then compounded by the pandemic. Since then, the unit has seen something of a financial recovery, with first half 2022 sales up 6% to $4.68

Biosimilars 105

Biosimilars Compounding Vaccines 105

Pharma Pathway

NOVEMBER 30, 2022

Job Role: Responsible for Executing Chemical reaction to synthesize required quantities of molecules/ compounds as per client specifications using efficient route and techniques. Set -up and executive reactions for synthesis of target molecules/ Compounds. Set -up and executive reactions for synthesis of target molecules/ Compounds.

Compounding 52

Compounding Vaccines 52

pharmaphorum

DECEMBER 14, 2021

Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage ulcerative colitis drug etrasimod. billion, and a few months after it snapped up Amplyx Pharmaceuticals and its anti-fungal compound fosmanogepix for an undisclosed sum.

Compounding 98

Compounding Vaccines 98

Pharma Pathway

SEPTEMBER 22, 2022

JD: Responsible for executing reactions to synthesize required quantities of molecules/ compounds as per client specifications using efficient route and techniques. Set -up and executive reactions for synthesize of target molecules/ Compounds. Work Location: Hyderabad. Maintain records, Data Integrity and IP Specifications.

Compounding 52

Compounding Vaccines 52

Express Pharma

APRIL 4, 2024

True enough, the use of liposomes and LNPs as carriers for highly specialised drug and biologic payloads, notably mRNA therapies, has experienced remarkable growth—notably, the initial SARS-CoV-2 vaccines authorised for use employed LNPs as delivery mechanisms for mRNA payloads. So, in that sense, both are effective in drug delivery.

Vaccines 98

Vaccines Compounding Immunity Immunization 98

pharmaphorum

APRIL 30, 2021

With RNA-based technology hitting the headlines in recent months due to its use in Covid vaccines, he also discusses the version of it that Galapagos uses and how it can produce compounds that might alter the course of a disease.

Compounding 52

Compounding Vaccines 52

Express Pharma

AUGUST 2, 2024

For instance, AI algorithms can analyse ( 4 ) millions of chemical compounds in one hour , a process that otherwise would take years to complete. In fact, during the COVID-19 vaccine discovery process, scientists across the globe ( 5 ) leveraged AI to run vaccine trials, expedite distribution and meet the needs of individuals.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Vaccines Compounding 69

pharmaphorum

FEBRUARY 3, 2022

As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases.

Compounding 52

Compounding Packaging Biosimilars Vaccines 52

Eye on FDA

JANUARY 5, 2022

Of note, this tally does not include meetings of the Vaccines and Related Biologic Products Advisory Committee held to consider a recommendation for COVID-19 vaccines, but includes only drugs and biologics. FDA Adcomms have been declining in number even as the agency approves more drugs.

Clinical Pharmacology 76

Clinical Pharmacology Vaccines Compounding Diabetes 76